Clinical Trials on Keratoconjunctival Epithelial Disorder
Total 163251 results
-
Groupe Hospitalier Diaconesses Croix Saint-SimonGERCOR - Multidisciplinary Oncology Cooperative GroupRecruitingOvarian Cancer, EpithelialFrance
-
Opna-IO LLCTerminatedEpithelial Ovarian Cancer | Gynecologic NeoplasmsUnited States, Canada
-
Shanghai East HospitalAnhui Provincial Hospital; Nanjing Legend Biotech Co.; East Clinical Center of...Terminated
-
National Cancer Centre, SingaporeTerminatedEpithelial Ovarian CancerSingapore
-
Translational Research in OncologyCelgeneTerminatedEpithelial Ovarian CancerUnited States
-
National University Hospital, SingaporeUnknownColorectal Cancer | Epithelial Ovarian Cancer | HNSCC | OrganoidsSingapore
-
RenJi HospitalCompletedEpithelial Ovarian CancerChina
-
Merck Sharp & Dohme LLCCompleted
-
Prima BioMed LtdCompleted
-
ARCAGY/ GINECO GROUPRoche Pharma AGCompleted
-
Translational Research in OncologyTerminatedOvarian NeoplasmsUnited States, France, Germany, Israel, Ireland, Spain, Canada, United Kingdom
-
MorphotekCompletedEpithelial Ovarian CancerUnited States
-
Russian Academy of Medical SciencesUnknownOvarian CancerRussian Federation
-
Cancer Research UKCompletedOvarian CancerUnited Kingdom
-
University of WashingtonNational Cancer Institute (NCI)CompletedFallopian Tube Cancer | Peritoneal Cavity Cancer | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Serous Cystadenocarcinoma | Stage IV Ovarian Epithelial Cancer | Recurrent Ovarian Epithelial Cancer | Stage III Ovarian Epithelial Cancer | Ovarian Mucinous Cystadenocarcinoma and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedFallopian Tube Cancer | Stage IV Breast Cancer | Stage IV Ovarian Epithelial Cancer | Recurrent Breast Cancer | Recurrent Ovarian Epithelial Cancer | Stage III Ovarian Epithelial Cancer | Female Reproductive CancerUnited States
-
Hanan JafarCompletedPersistent Corneal Epithelial DefectJordan
-
Peking University Third HospitalSOTIO a.s.RecruitingFallopian Tube Carcinoma | Primary Peritoneal Carcinoma | Epithelial Ovarian CarcinomaChina
-
Shandong UniversityRecruitingObjective Response RateChina
-
National Cancer Centre, SingaporeCompleted
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityUnknownPredictive Cancer ModelChina
-
Priv.-Doz. Dr. med. Joachim RomCompletedEpithelial Ovarian CancerGermany
-
National Cancer Institute (NCI)CompletedOvarian CancerUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)TerminatedOvarian CancerUnited States
-
Accelerated Community Oncology Research NetworkGenentech, Inc.; Celgene CorporationCompletedEpithelial Ovarian Cancer | Primary Peritoneal CarcinomaUnited States
-
GERCOR - Multidisciplinary Oncology Cooperative...Unknown
-
Combangio, IncKala Pharmaceuticals, Inc.RecruitingPersistent Corneal Epithelial DefectUnited States
-
Amber Ophthalmics, Inc.RecruitingCorneal Persistent Epithelial DefectUnited States
-
Kiora Pharmaceuticals, Inc.CompletedPersistent Corneal Epithelial DefectMexico
-
Noveome Biotherapeutics, formerly StemnionCompletedPersistent Corneal Epithelial DefectUnited States
-
New Mexico Cancer Care AllianceNational Cancer Institute (NCI)CompletedCervical Cancer | Ovarian Epithelial Cancer | Uterine Sarcoma | Vulvar Cancer | Endometrial Cancer | Ovarian Germ Cell TumorUnited States
-
Oregon Health and Science UniversityOregon Clinical and Translational Research InstituteCompletedContraceptive Usage | Vaginal Epithelial DisruptionUnited States
-
Andrasko, Gary, OD, LLCAlcon ResearchUnknownCorneal Staining | Corneal Epithelial DisruptionUnited States
-
Samsung Medical CenterCompletedThymic Epithelial Tumors
-
ImmunoVaccine Technologies, Inc. (IMV Inc.)TerminatedMaveropepimut-S (MVP-S) and Low-Dose CPA in Patients With Platinum-Resistant Ovarian Cancer (AVALON)Platinum-resistant Epithelial Ovarian CancerUnited States, Canada, Puerto Rico
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Ovarian Epithelial CancerUnited States
-
AGO Study GroupPhilipps University Marburg Medical Center; HSK Reasearch GmbH WiesbadenCompletedPlatinum Refractory Epithelial Ovarian Cancer | Primary Cancer of the Peritoneum | Cancer of the Fallopian TubeGermany
-
University of WashingtonNational Cancer Institute (NCI)CompletedFallopian Tube Cancer | Peritoneal Cavity Cancer | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Serous Cystadenocarcinoma | Stage IV Ovarian Epithelial Cancer | Brenner Tumor | Recurrent Ovarian Epithelial Cancer | Stage III Ovarian Epithelial Cancer | Ovarian Mucinous... and other conditionsUnited States
-
Anne Fung MDGenentech, Inc.TerminatedMacular Degeneration | Wet Macular Degeneration | Retinal Pigment Epithelial DetachmentUnited States
-
Tennessee RetinaRegeneron PharmaceuticalsUnknownAge Related Macular Degeneration | Pigment Epithelial DetachmentUnited States
-
Shanghai Gynecologic Oncology GroupZhejiang Cancer Hospital; Sun Yat-sen University; Fudan University; Shanghai Zhongshan...Active, not recruitingFallopian Tube Carcinoma | Ovarian Epithelial Cancer Recurrent | Primary Peritoneal CarcinomaChina
-
Fox Chase Cancer CenterCompletedFallopian Tube Cancer | Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial CancerUnited States
-
TetraLogic PharmaceuticalsCompletedRelapsed Epithelial Ovarian Cancer | Relapsed Primary Peritoneal Cancer | Relapsed Fallopian Tube CancerUnited States
-
Catholic University of the Sacred HeartCompletedOvarian Epithelial Cancer Recurrent
-
Cukurova UniversityRecruitingEpithelial Ovarian Cancer | Rectosigmoid Cancer MetastaticTurkey
-
National Cancer Centre, SingaporeBristol-Myers Squibb; OncoQuest Pharma USA Inc.UnknownEpithelial Ovarian CancerSingapore
-
Icahn School of Medicine at Mount SinaiWithdrawn
-
National Cancer Center, KoreaAjou UniversityCompletedEpithelial Ovarian CancerKorea, Republic of
-
Montefiore Medical CenterNational Cancer Institute (NCI)CompletedOvarian Cancer | Peritoneal Cavity CancerUnited States
-
PEDRO VILLAREJO CAMPOSUniversity of Castilla-La Mancha; Hospital General de Ciudad RealUnknownEpithelial Ovarian CancerSpain